Ibrutinib Targets microRNA-21 in Multiple Myeloma Cells by Inhibiting NF-κB and STAT3

Tumor Biology - United States
doi 10.1177/1010428317731369
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Regulation of STAT3 and NF-κB Activations by S-Nitrosylation in Multiple Myeloma

Free Radical Biology and Medicine
BiochemistryPhysiology
2017English

Icaritin Suppresses Multiple Myeloma, by Inhibiting IL-6/JAK2/STAT3

Oncotarget
Oncology
2015English

Wogonin Reversed Resistant Human Myelogenous Leukemia Cells via Inhibiting Nrf2 Signaling by Stat3/NF-κB Inactivation

Scientific Reports
Multidisciplinary
2017English

Betulinic Acid Induces ROS-Dependent Apoptosis and S-Phase Arrest by Inhibiting the NF-κB Pathway in Human Multiple Myeloma

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2019English

Combination Chemotherapy Increases Cytotoxicity of Multiple Myeloma Cells by Modification of Nuclear Factor (NF)-κB Activity

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2013English

NF-κB and STAT3 Cooperatively Induce IL6 in Starved Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

NF-κB and Cancer—identifying Targets and Mechanisms

Current Opinion in Genetics and Development
GeneticsDevelopmental Biology
2008English

CDK4 Inhibitors Thwart Immunity by Inhibiting Phospho-Rb-Nf-κB Complexes

Molecular Cell
Cell BiologyMolecular Biology
2019English

A Cell-Penetrating Peptide Suppresses Inflammation by Inhibiting NF-κB Signaling

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy